Mostafa Moin

Mostafa Moin

Auto-generated profile, based on publicly available information

Mostafa Moin

Immunology, Asthma and Allergy Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 November 2005 in Nutrition Journal
Verified
Journal Article
Open access
PDF file
RSReza Safaralizadeh
Reza Safaralizadeh
GKGa Kardar
Ga Kardar
ZPZ Pourpak
Z Pourpak
MMM Moin
M Moin
AZA Zare
A Zare
STS Teimourian
S Teimourian
Objective: To investigate whether daily diet provides adequate selenium intake in healthy men and women living in Tehran, Iran. Method: Serum level of selenium was determined in 184 healthy individuals of both genders. The samples were divided into two age groups, adults and children, for analysis. The serum level of selenium was determined using hydride generation and flame atomic absorption spectroscopy. Results: The mean and standard deviation of serum selenium levels in children (1–16 years) was 84.3 ± 11 μg/l and there was no significant difference between genders in this group. In adults (older than 16 years) the mean serum selenium level was 100.6 ± 13 SD μg/l; among women the mean was 93.9 ± 14 SD μg/l and among men it was 102.2 ± 12 SD μg/l. The mean selenium level in men was higher than in women and data analysis showed a significant difference between them (p < 0.005). There was also a positive correlation between higher selenium serum concentration and age in men (P < 0.001). Daily intake of selenium in men and women was calculated to be 67 μg and 62.1 μg respectively. Conclusion: Our results show that the serum concentration of selenium in an Iranian population is similar to other nationalities in the Middle East, particularly Saudi Arabia.

4 January 2018 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
PDF file
MFMohammad Reza Fazlollahi
Mohammad Reza Fazlollahi
MNMehdi Najmi
Mehdi Najmi
MFMojtaba Fallahnezhad
Mojtaba Fallahnezhad
NSNastaran Sabetkish
Nastaran Sabetkish
AKAnoushiravan Kazemnejad
Anoushiravan Kazemnejad
MMMostafa Moin
Mostafa Moin

1 October 2020 in International Journal of Infectious Diseases
Verified
Journal Article
Open access
PDF file
ESEhsan Shamsi-Gooshki
Ehsan Shamsi-Gooshki
APAlireza Parsapoor
Alireza Parsapoor
FAFariba Asghari
Fariba Asghari
MPMojtaba Parsa
Mojtaba Parsa
YSYasaman Saeedinejad
Yasaman Saeedinejad
MMMostafa Moin
Mostafa Moin
Background: The medical profession has always been an inspiration for human societies throughout its diverse history. This position and historical authority in the field of ethics has had a different and higher status, in such a way that many of the norms of general ethics and professional ethics, especially principles, such as trust, confidentiality and respect for human dignity, have been developed by medical professionals. Developing guidelines of general and professional ethics is one of the inherent duties of the Medical Council of the Islamic Republic of Iran (IRIMC) as a professional organization. In this regard, the Supreme Council of IRIMC has approved the "Code of Ethics for Medical Professionals" and, in accordance with its legal authority, has annexed it to the disciplinary regulations of IRIMC. Methods: A draft document, the result of extensive literature review, was discussed in 27 expert panel meetings and after receiving and endorsing the stakeholders’ point of view, was approved by the IRIMC Supreme Council. Results: The first edition of "Code of Ethics for Medical Professionals, Medical Council of Islamic Republic of Iran" was developed on July 6, 2017 by the Supreme Council of IRIMC. The guideline was set to take effect one year after its enactment. The first edition was revised and completed and final edition was adopted on August 9, 2018 by IRIMC in 13 chapters and 140 articles (original full text is available in the Supplementary file 1). Conclusion: According to the approved decision by the Supreme Council of IRIMC on May 10, 2018, the final edition takes effect as of October 7, 2018.

25 November 2018 in The Clinical Respiratory Journal
Verified
Journal Article
Closed access
PDF file
MFMohammad Reza Fazlollahi
Mohammad Reza Fazlollahi
MNMehdi Najmi
Mehdi Najmi
MFMojtaba Fallahnezhad
Mojtaba Fallahnezhad
NSNastaran Sabetkish
Nastaran Sabetkish
AKAnoshirvan Kazemnejad
Anoshirvan Kazemnejad
MMMostafa Moin
Mostafa Moin

1 January 2006 in Scandinavian Journal of Infectious Diseases
Verified
Journal Article
Closed access
MMMostafa Moin
Mostafa Moin
AFAbolhassan Farhoudi
Abolhassan Farhoudi
MMMasoud Movahedi
Masoud Movahedi
NRNima Rezaei
Nima Rezaei
ZPZahra Pourpak
Zahra Pourpak
AAAsghar Aghamohammadi
Asghar Aghamohammadi
In order to determine the clinical and laboratory findings of Iranian patients with presumed hyper-immunoglobulin E syndrome (HIES), the medical records of 22 patients from 21 unrelated families, who had been registered in the Iranian Primary Immunodeficiency Registry, were observed. The median age of patients at the time of first symptom and at the time of diagnosis was 1 month and 52.5 months, respectively, with a median diagnosis delay of 70 months. 13 families had consanguineous marriages. IgE level was higher than 2000 IU/ml in all patients, ranging from >2000 to 80,000 IU/ml. The most commonly occurring manifestations were: eczema and dermatitis, pneumonia, upper respiratory tract infections, cutaneous abscesses, diarrhoea, deep abscesses, and otitis media. Other less frequent manifestations were: mucocutaneous candidiasis, sinusitis, cutaneous ulcers, Molluscum contagiosum, herpetic keratitis, onychomycosis, conjunctivitis, septic arthritis, and meningitis. Five patients were complicated by bronchiectasis due to recurrent pneumonia and 5 patients died because of severe infections and malignancy. The HIES is a multisystem disorder that affects especially cutaneous, respiratory, skeletal and the immune system. Although HIES is a rare condition, the recurrent infections should always raise a suspicion, which deserves further evaluation for detecting the syndrome.

1 April 2012 in International Immunopharmacology
Verified
Journal Article
Closed access
FBFariba Naderi Beni
Fariba Naderi Beni
FFFatemeh Fattahi
Fatemeh Fattahi
AMAbbas Mirshafiey
Abbas Mirshafiey
MAMohammad Ansari
Mohammad Ansari
MMMonireh Mohsenzadegan
Monireh Mohsenzadegan
MMMostafa Moin
Mostafa Moin